ME

Medpace

- NASDAQ:MEDP
Last Updated 2024-04-19

LinkedIn Profile

Access Medpace historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:medp 24015 Apr 14th, 2024 12:00AM Medpace 215K 5567 Open Apr 13th, 2024 11:21PM Apr 14th, 2024 11:19AM Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries. Open Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals Open 5375 Medpace Way Cincinnati OH US 45227 Medpace
nasdaq:medp 24015 Apr 13th, 2024 12:00AM Medpace 215K 5569 Open Apr 12th, 2024 11:12PM Apr 13th, 2024 11:46AM Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries. Open Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals Open 5375 Medpace Way Cincinnati OH US 45227 Medpace
nasdaq:medp 24015 Apr 12th, 2024 12:00AM Medpace 215K 5569 Open Apr 11th, 2024 11:17PM Apr 12th, 2024 08:41AM Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries. Open Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals Open 5375 Medpace Way Cincinnati OH US 45227 Medpace
nasdaq:medp 24015 Apr 11th, 2024 12:00AM Medpace 215K 5567 Open Apr 10th, 2024 11:50PM Apr 11th, 2024 11:26AM Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries. Open Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals Open 5375 Medpace Way Cincinnati OH US 45227 Medpace
nasdaq:medp 24015 Apr 10th, 2024 12:00AM Medpace 215K 5570 Open Apr 9th, 2024 11:20PM Apr 10th, 2024 05:34PM Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries. Open Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals Open 5375 Medpace Way Cincinnati OH US 45227 Medpace
nasdaq:medp 24015 Apr 9th, 2024 12:00AM Medpace 214K 5569 Open Apr 8th, 2024 11:31PM Apr 9th, 2024 10:16AM Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries. Open Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals Open 5375 Medpace Way Cincinnati OH US 45227 Medpace
nasdaq:medp 24015 Apr 8th, 2024 12:00AM Medpace 214K 5568 Open Apr 7th, 2024 11:55PM Apr 8th, 2024 07:13PM Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries. Open Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals Open 5375 Medpace Way Cincinnati OH US 45227 Medpace
nasdaq:medp 24015 Apr 7th, 2024 12:00AM Medpace 214K 5566 Open Apr 6th, 2024 11:26PM Apr 6th, 2024 11:26PM Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries. Open Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals Open 5375 Medpace Way Cincinnati OH US 45227 Medpace
nasdaq:medp 24015 Apr 6th, 2024 12:00AM Medpace 214K 5566 Open Apr 5th, 2024 11:26PM Apr 5th, 2024 11:26PM Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries. Open Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals Open 5375 Medpace Way Cincinnati OH US 45227 Medpace
nasdaq:medp 24015 Apr 5th, 2024 12:00AM Medpace 214K 5561 Open Apr 4th, 2024 11:54PM Apr 4th, 2024 11:54PM Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 41 countries. Open Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals Open 5375 Medpace Way Cincinnati OH US 45227 Medpace

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.